Evaluating the Safety and Tolerability of Etravirine in HIV-1 Infected Infants and Children
- First Posted Date
- 2012-01-05
- Last Posted Date
- 2021-11-02
- Target Recruit Count
- 26
- Registration Number
- NCT01504841
- Locations
- 🇧🇷
SOM Federal University Minas Gerais Brazil NICHD CRS, Belo Horizonte, Minas Gerais, Brazil
🇧🇷Hosp. Geral De Nova Igaucu Brazil NICHD CRS, Rio de Janeiro, Brazil
🇺🇸Bronx-Lebanon Hospital Center NICHD CRS, Bronx, New York, United States
Seasonal Influenza DNA Vaccine Prime With Trivalent Inactivated Vaccine (TIV) Boost Compared to TIV Alone
- Conditions
- Influenza
- Interventions
- Biological: DNA vaccineBiological: TIV
- First Posted Date
- 2011-12-23
- Last Posted Date
- 2016-03-24
- Target Recruit Count
- 131
- Registration Number
- NCT01498718
- Locations
- 🇺🇸
St. Louis University - Doisy Research Center, St. Louis, Missouri, United States
🇺🇸Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
🇺🇸Baylor College of Medicine, Houston, Texas, United States
Evaluating the Safety of Immediate Versus Deferred Isoniazid Preventive Therapy Among HIV-Infected Pregnant Women
- Conditions
- TuberculosisHIV Infections
- Interventions
- Drug: Placebo for isoniazid (INH)
- First Posted Date
- 2011-12-16
- Last Posted Date
- 2021-11-05
- Target Recruit Count
- 956
- Registration Number
- NCT01494038
- Locations
- 🇧🇼
Gaborone CRS, Gaborone, Botswana
🇧🇼Molepolole CRS, Gaborone, Botswana
🇭🇹Les Centres GHESKIO Clinical Research Site (GHESKIO-INLR) CRS, Port-au-Prince, Haiti
Registry for the Atopic Dermatitis Research Network
- Conditions
- Eczema HerpeticumAtopic Dermatitis
- First Posted Date
- 2011-12-16
- Last Posted Date
- 2018-09-19
- Target Recruit Count
- 3387
- Registration Number
- NCT01494142
- Locations
- 🇺🇸
Oregon Health & Science University, Portland, Oregon, United States
🇺🇸Icahn School of Medicine at Mount Sinai, New York, New York, United States
🇺🇸Children's Hospital Los Angeles, Los Angeles, California, United States
Evaluating the Safety of Tenofovir Vaginal Gel in HIV-Uninfected Pregnant Women
A Study to Determine the Immunogenicity and Oral Tolerance to Keyhole Limpet Hemocyanin (KLH)
- Conditions
- Autoimmune Disorders
- Interventions
- Biological: Immucothel+Montanide (Part A)Biological: Immucothel Alone (Part A)Biological: Immucothel Alone or Immucothel+Montanide (Part B)
- First Posted Date
- 2011-12-12
- Last Posted Date
- 2016-04-12
- Target Recruit Count
- 19
- Registration Number
- NCT01489956
- Locations
- 🇺🇸
Mount Sinai Medical Center, New York, New York, United States
Chikungunya Virus Vaccine Trial in Healthy Adults
- Conditions
- Chikungunya FeverChikungunya Virus InfectionViral Vaccines
- Interventions
- Biological: VRC-CHKVLP059-00-VP
- First Posted Date
- 2011-12-09
- Last Posted Date
- 2016-07-25
- Target Recruit Count
- 25
- Registration Number
- NCT01489358
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Evaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV Infection
- Conditions
- Hepatitis CHIV Infections
- Interventions
- First Posted Date
- 2011-12-01
- Last Posted Date
- 2021-11-04
- Target Recruit Count
- 262
- Registration Number
- NCT01482767
- Locations
- 🇺🇸
Rush University CRS, Chicago, Illinois, United States
🇺🇸Case Clinical Research Site, Cleveland, Ohio, United States
🇺🇸MetroHealth CRS, Cleveland, Ohio, United States
Evaluating the Immune Response to a rAd5 HIV Vaccine Administered in Three Different Ways in Healthy, HIV-Uninfected Adults
- Conditions
- HIV Infections
- Interventions
- Biological: rAd5 env ABiological: VRC rAd5 vaccine (rAd5 gag-pol/env A/B/C)Biological: Placebo VaccineBiological: rAd5 env BBiological: rAd5 env CBiological: rAd5 gag-pol
- First Posted Date
- 2011-11-24
- Last Posted Date
- 2021-10-15
- Target Recruit Count
- 90
- Registration Number
- NCT01479296
- Locations
- 🇺🇸
New York Blood Center CRS, New York, New York, United States
🇺🇸Bridge HIV CRS, San Francisco, California, United States
🇺🇸UIC Project WISH CRS, Chicago, Illinois, United States
Quadrivalent HPV Vaccine to Prevent Anal HPV in HIV-infected Men and Women
- Conditions
- HIV Infections
- Interventions
- Biological: Placebo Vaccine for Male Participants OnlyBiological: Quadrivalent HPV VaccineBiological: Placebo Vaccine for Female Participants Only
- First Posted Date
- 2011-10-27
- Last Posted Date
- 2021-11-02
- Target Recruit Count
- 575
- Registration Number
- NCT01461096
- Locations
- 🇺🇸
Ucsf Hiv/Aids Crs, San Francisco, California, United States
🇺🇸UCLA CARE Center CRS, Los Angeles, California, United States
🇺🇸Rush University CRS, Chicago, Illinois, United States